𝐁𝐢𝐨𝐌𝐨𝐝𝐞𝐥𝐬 𝐢𝐬 𝐞𝐱𝐜𝐢𝐭𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐞 𝐥𝐚𝐮𝐧𝐜𝐡 𝐨𝐟 𝐚𝐧 𝐞𝐧𝐭𝐢𝐫𝐞𝐥𝐲 𝐧𝐞𝐰 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐡𝐚𝐭 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐬 𝐌𝐢𝐬𝐬𝐢𝐨𝐧 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞! At BioModels, we are focused on providing our clients with the ultimate experience in preclinical research services. Our new brand identity/tagline: “𝐌𝐢𝐬𝐬𝐢𝐨𝐧 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞” directly reflects the urgency and significance of each project that we execute. We’re dedicated to working with you to be on the cutting edge of scientific innovation and drug development. 𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐧𝐞𝐰 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 (www.biomodels.com) or contact us with any questions and/or to set up a time to discuss a potential collaboration. We are excited to be your Mission Critical Science partner! Together let’s continue to improve treatment options for patients and expand personalized medicine.
BioModels’ Post
More Relevant Posts
-
TRANSLATIONAL RESEARCH DESIGN 🔍 Looking for innovative ways to revolutionize healthcare? Dive into the world of Translational Research Design! 🚀✨ 💡 Explore the transformative potential of bridging the gap between scientific discoveries and practical applications. 🔬 Our cutting-edge solutions in translational research design empower businesses to: 1. Accelerate drug development processes. 2. Enhance patient care and outcomes. 3. Drive breakthroughs in medical technology. Ready to transform your research into real-world impact? Let's collaborate! CLICK LINK IN BIO
To view or add a comment, sign in
-
We understand the challenges and complexities of developing new treatments. We know that every step in the drug development process, from preclinical research to post-marketing surveillance, requires precision, efficiency, and a patient-centric approach. That’s why we have developed cutting-edge tools like ObjectiveScreen, ObjectiveView, and ObjectiveCare. These tools allow us to conduct rigorous research, monitor patient health in real-time, and connect patients with emerging treatment options. By partnering with us, you can leverage our technology and expertise to accelerate your drug development process, improve patient recruitment and retention, and ultimately, bring your innovative treatments to the patients who need them most. We are not just a technology company, we are a community of healthcare professionals, researchers, and patients who are committed to improving patient outcomes and advancing medical research. Learn more: https://objective.health/
To view or add a comment, sign in
-
Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/gvyxpPGY #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions
To view or add a comment, sign in
-
Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/ggCK5CRW #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions
Site Spotlight: EmVenio Research - How EmVenio is Leveraging Technology to Increase Diversity in Clinical Trials
post.dsmn8.com
To view or add a comment, sign in
-
IT Director | Expert in Cybersecurity, System Integration, and Cloud Solutions | Proven Leader in IT Governance and Compliance
Expanding access to clinical trials is crucial for improving health outcomes and advancing inclusive medical research. In our latest Site Spotlight, we explore how EmVenio Research is using technology to broaden research access and foster diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we explore their innovative business approach and the impactful work they're doing in underserved communities. EmVenio is making a difference by setting up clinical trial sites in areas with little to no prior trial activity and by incorporating advanced eClinical solutions, like the RealTime-SOMS eClinical suite. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's innovative work and future plans: https://lnkd.in/gQMHxgSa #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions
Site Spotlight: EmVenio Research - How EmVenio is Leveraging Technology to Increase Diversity in Clinical Trials
post.dsmn8.com
To view or add a comment, sign in
-
PhD in Nanotechnology-Head of Pharmaceutical Export and International Affairs at Iran Food and Drug Administration
#Medical_Research, as a dynamic field, encompasses a wide spectrum of investigations, ranging from the microscopic intricacies of cellular function to the macroscopic challenges of public health. Here, we are going to continue the previous note by providing a short brief of two other fields of 10 top medical research trends in 2024: 1- Novel Drug Development 2- Medical Regulatory Technology #Novel_Drug_Development stands at the forefront of scientific innovation, representing a multifaceted and dynamic process that transforms promising compounds into therapeutic agents. The overarching goal is to #discover and bring to market #new_medications that address unmet medical needs, improve patient outcomes, and advance the landscape of #healthcare. #Medical_Regulatory_Technology, often referred to as MedTech, represents a rapidly evolving field at the intersection of healthcare, technology, and #regulatory_compliance. It encompasses a diverse range of technological solutions designed to streamline and enhance various aspects of healthcare regulation, ensuring that medical products and services meet stringent standards for safety, efficacy, and quality. (StartUs Insights)
To view or add a comment, sign in
-
Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/ert6ZQGW #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions
Site Spotlight: EmVenio Research - How EmVenio is Leveraging Technology to Increase Diversity in Clinical Trials
post.dsmn8.com
To view or add a comment, sign in
-
In the realms of biotech, biopharma, and medical devices, your customers are often scientists, researchers, and healthcare professionals. While the technical features of your innovations are important, it's crucial to connect with these expert customers on a deeper level. 🌟 Instead of solely focusing on features, consider: - How does your product or service advance scientific research? - What real-world problems does it solve for the scientific community? - How does it improve the efficiency and effectiveness of their work? Here's why connecting with scientists is essential: 1) Shared Understanding: Scientists appreciate a partner who understands their challenges and speaks their language. Use evidence-based communication to show you get their needs. 2) Highlight Impact: Demonstrate the real-world applications and benefits of your product. Show how it can lead to groundbreaking discoveries or improve patient outcomes. 3) Build Trust: Establish credibility by sharing success stories, clinical data, and peer-reviewed studies that validate your product's effectiveness. When you focus on the value and impact your innovations bring to the scientific community, you build stronger, more meaningful relationships. 🌐 Ready to elevate your communication strategy? Let’s discuss how to effectively connect with your scientist customers and highlight the transformative impact of your products. 💡 Schedule a discovery call at www.yoanneclovis.com to refine your approach to engaging with the scientific community. #Biotech #Biopharma #MedDevice #ScientificResearch #HealthcareInnovation #CustomerEngagement #BrandMessaging #MarketingStrategy #BusinessGrowth
To view or add a comment, sign in
-
Senior Medical Science Liaison at Bayer | Doctorally-Prepared Physician Associate | Lifescience Industry Professional | Emerging Medical Technology Aficionado | *Posts and opinions are my own, not that of my employer.
Speaking of the lifescience industry in general… A clinical study is not about confirming what you WANT to be true, AKA confirmation bias. Data and evidence drives conclusions, which drives the to-market strategy for new treatments and technologies. You may have a desire to fulfill a certain need, and facilitate research evaluating safety and efficacy in that indication - but you must be prepared to accept the truth. And that may not be want you want it to be, or what would be best for your company. Of course, sometimes it is. And if it is, have a plan for submission, dissemination, and scientific engagement to ride that wave to success. #research #innovation #evidencebasedpractice #medicalscienceliaison #medicalaffairs
To view or add a comment, sign in
-
🔬LabOps & LabEx Webinar: Accelerate Time to Science with Urgent Digital Transformation 🔬 Are traditional lab design and change management processes slowing down your time to market for life-saving therapies? Discover how the Lab Design Tool has helped companies digitally transform laboratory operations by reclaiming critical time for scientists, enhancing collaboration, and optimizing lab spaces for breakthrough science. Why Attend? ☑ Accelerate lab innovation and planning for faster, more efficient results. ☑ Streamline decision-making to unlock significant cost savings, enhanced flexibility, and improved compliance and safety. ☑ Optimize space utilization and eliminate lab design inefficiencies with cutting-edge digital strategies. ☑ Experience a LIVE demonstration of a lab digital twin, showcasing how innovation and integration drive comprehensive analysis and better laboratory outcomes. 📅 When? Tuesday, September 24th at Noon EST [RSVP: https://lnkd.in/gJ8QFBwk] Tuesday, September 24th at Noon CEST [RSVP: https://lnkd.in/gCQvSerG] #labops #labexcellence #spaceplanning #labdesign #spaceplanner #laboperations #labsafty #laboptimization #pharma #biotech
To view or add a comment, sign in
683 followers